Mardi Dier Madrigal Pharmaceuticals, Inc. (MDGL) insider trading activity

Mardi Dier is EVP and CFO of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 10,440 shares of MDGL, which is worth approximately $5.52 Million. The most recent transaction as insider was on Dec 02, 2025, when has been sold 4,173 shares (Common Stock) at a price of $581.45 per share, resulting in proceeds of $2,426,390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4K

0% 3M change

n/a 12M change

Total Value Held $5.52 Million

Mardi Dier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2025	SELL Open market or private sale	$2,426,390 $581.45 p/Share	4,173 Reduced 28.56%	10,440 Common Stock
Dec 02 2025	BUY Exercise of conversion of derivative security	$1,050,051 $251.63 p/Share	4,173 Added 22.21%	14,613 Common Stock
Mar 10 2025	SELL Open market or private sale	$83,344 $323.04 p/Share	258 Reduced 2.41%	10,440 Common Stock
Mar 05 2025	BUY Grant, award, or other acquisition	-	3,784 Added 26.13%	10,698 Common Stock
Mar 03 2025	SELL Open market or private sale	$636,775 $324.72 p/Share	1,961 Reduced 22.1%	6,914 Common Stock

Also insider at

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

CFO & Executive Vice President

ORIC

Oric Pharmaceuticals, Inc. Healthcare

PRLD

Prelude Therapeutics Inc Healthcare

SLRN

ACELYRIN, Inc.

CFO and CBO

Mardi Dier

EVP and CFO

Novato, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Value

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

Operation

Value

Type

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Track Activities on MDGL

Account